M&A Deal Summary

Partners Group and GHO Capital Partners Acquire FairJourney Biologics

On July 1, 2024, asset manager Partners Group and private equity firm GHO Capital Partners acquired life science company FairJourney Biologics from GHO Capital Partners

Acquisition Highlights
  • This is Partners Group’s 4th and GHO Capital Partners’ 14th transaction in the Life Science sector.
  • This is Partners Group’s 2nd and GHO Capital Partners’ 2nd transaction in Portugal.

M&A Deal Summary

Date 2024-07-01
Target FairJourney Biologics
Sector Life Science
Buyer(s) Partners Group
GHO Capital Partners
Sellers(s) GHO Capital Partners
Deal Type Secondary Buyout

Target

FairJourney Biologics

Porto, Portugal
FairJourney Biologics is a biologics CRO, providing integrated services across antibody discovery, engineering, and production to global biopharma. The company operates a flexible, customer-oriented ‘one-stop-shop’ approach to biologics development focused on quality, reliability, and partnership. FairJourney Biologics was founded in 2012 and is based in Porto, Portugal.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 2

Buyer

Partners Group

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 1996
PE ASSETS 174.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Partners Group is a global investment management firm with a variety of funds and institutional clients. The Firm's direct investment group looks to invest in or acquire market leading companies with growth opportunities linked to technology. Partners is a hands-on investor and looks to actively support its portfolio companies with expansion, operational, and governance structure support. Partners Group was established in 1996 and is headquartered in Zug, Switzerland.


DEAL STATS #
Overall 95 of 97
Sector: Life Science M&A 4 of 4
Type: Secondary Buyout M&A Deals 52 of 53
Country: Portugal M&A 2 of 2
Year: 2024 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-11 Velvet CARE

Klucze, Poland

Velvet CARE is a manufacturer of tissue-based, personal hygiene products in CEE, producing toilet paper, kitchen paper and hand tissues sold under the Velvet brand. Velvet CARE was founded in 1897 and is based in Klucze, Poland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-01 Techem

Eschborn, Germany

Techem specializes in smart and sustainable solutions for the real estate industry, focusing on energy efficiency and decarbonization. Techem provides digital services that help reduce energy consumption, improve water management, and increase resource conservation across properties. Techem's comprehensive offerings include remote monitoring systems for heating and water, wireless smoke detectors, and solutions for enhancing energy efficiency in buildings. Techem was founded in 1952 and is based in Eschborn, Germany.

Sell €6.7B
Buyer

GHO Capital Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2014
PE ASSETS 6.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.


DEAL STATS #
Overall 22 of 25
Sector: Life Science M&A 14 of 16
Type: Secondary Buyout M&A Deals 11 of 12
Country: Portugal M&A 2 of 2
Year: 2024 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-01 Sapio Sciences

Baltimore, Maryland, United States

Sapio Sciences is a lab informatics platform providing LIMS, ELN and Data management solutions to Biopharma, CROs and clinical diagnostic labs. Sapio Sciences was founded in 2004 and is based in Baltimore, Maryland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-06 Avid Bioservices

Tustin, California, United States

Avid Bioservices is a CDMO focused on development and CGMP manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Avid Bioservices is based in Tustin, California.

Buy $1.1B

Seller(S) 1

SELLER

GHO Capital Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2014
PE ASSETS 6.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.


DEAL STATS #
Overall 4 of 5
Sector: Life Science M&A 4 of 5
Type: Secondary Buyout M&A Deals 2 of 2
Country: Portugal M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-01 Sapio Sciences

Baltimore, Maryland, United States

Sapio Sciences is a lab informatics platform providing LIMS, ELN and Data management solutions to Biopharma, CROs and clinical diagnostic labs. Sapio Sciences was founded in 2004 and is based in Baltimore, Maryland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-06 Avid Bioservices

Tustin, California, United States

Avid Bioservices is a CDMO focused on development and CGMP manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Avid Bioservices is based in Tustin, California.

Buy $1.1B